Revelation Biosciences Inc. $(REVB)$ announced a 1-for-3 reverse stock split effective July 7, 2025, following approval at a Special Meeting of Stockholders. This move aims to increase the market price per share to comply with Nasdaq's listing requirements. The company's common stock will trade on a post-split basis under the existing symbol "REVB" starting that day.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.